机构:[1]Department of Hepatobiliary Surgery 1, Institute of Hepatobiliary-Pancreatic-Intestinal Diseases, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan nan Road, Shunqing District, Nanchang, 637000, China. 595247406@qq.com.[2]Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchang, 637000, China.
The study was supported by Science and Technology Department Foundation
of Nanchong (No. 20SXQT0143).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|3 区医学
小类|3 区肿瘤学
最新[2023]版:
大类|2 区医学
小类|3 区肿瘤学
第一作者:
第一作者机构:[1]Department of Hepatobiliary Surgery 1, Institute of Hepatobiliary-Pancreatic-Intestinal Diseases, Affiliated Hospital of North Sichuan Medical College, No. 1 Maoyuan nan Road, Shunqing District, Nanchang, 637000, China. 595247406@qq.com.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Xu Jian,Zhang Wei.EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway.[J].Cancer cell international.2021,21(1):521.doi:10.1186/s12935-021-02222-1.
APA:
Xu Jian&Zhang Wei.(2021).EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway..Cancer cell international,21,(1)
MLA:
Xu Jian,et al."EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway.".Cancer cell international 21..1(2021):521